Compositions to Enhance and Extend Quality of Life

Patent metadata

Field	Value
Publication number	US-2025152562-A1
Application number	US-202519021597-A
Country	US
Kind code	A1
Filing date	Jan 15, 2025
Priority date	Jul 26, 2017
Publication date	May 15, 2025
Grant date	—

Abstract

The present invention discloses a system and method for preparing and delivering health and longevity compositions. This invention is designed to improve the quality of life and lifespan of mammals. Compositions of the present invention are selected and designed for the purpose of efficiently delivering health and longevity enhancing therapies through oral supplementation; misting; nasal spray; intravenous, IM, and/or sub-cutaneous, injection; suppository; etc. A non-toxic therapeutic anabolic hormone replenishment is combined with rapamycin and cannabidiol. The three compounds work together to improve quality of life and healthy lifespan. Preferred additional supplements may include metformin, growth hormone, and/or supplemented minerals. A preferred embodiment features low dose continuous supplementation, e.g., incorporated with daily meals. Processes of the present invention delivers an orally ingested substance, e.g., a snack, a human food supplement, an animal treat, etc., that contains the active compounds to be absorbed by the digestive system or delivered into the bloodstream.

First claim

1 . A composition comprising an androgenic prohormone, rapamycin, and a cannabinoid compound that binds and stimulates a mammalian endocannabinoid receptor in a delivery route selected from the group consisting of: topical, injectable, and oral.

2 . The composition of claim 1 wherein the delivery route is oral in a format selected from the group consisting of: a liquid, a suspension, a tablet, a capsule, and a gummi.

3 . The composition of claim 1 wherein said delivery route is injectable in a format selected from the group consisting of: an emulsion, a solution, a suspension, and subdermal implant.

4 . The composition of claim 1 wherein said delivery route is topical in a format selected from the group consisting of: a liquid, a suspension, a lotion, a spray, a patch, a spritz, a balm, a salve, and an ointment.

5 . The composition of claim 1 said prohormone is selected from the group consisting of: DHEA, 7-keto DHEA and DHEA-S.

6 . The composition of claim 1 wherein said endogenous endocannabinoid receptor is selected from the group consisting of: CB1, CB2, TRPV1, TRPV2, TRPV3, TRPV4, TRPA1, TRPM8, GPR18, GPR119, GPR55, GPR118 and non-human analogues thereto.

7 . The composition of claim 1 wherein said cannabinoid compound comprises cannabidiol (CBD).

8 . The composition of claim 6 wherein said cannabinoid compound also binds and stimulates at least one 5-HT receptor.

9 . The composition of claim 1 further comprising an oil selected from the group consisting of: vegetable, rapeseed/canola, soy, corn, peppermint, lavender, sandalwood, bergamot, rose, chamomile, ylang-ylang, tea tree, myrcene/hops, jasmine, and lemon.

10 . The composition of claim 1 further comprising nutmeg or nutmeg extract.

11 . The composition of claim 1 present in an edible selected from the group consisting of: a toothpaste, a feed, a spritz, a small treat, a food formulation, a food supplement, a gummi, a prescription food product, a capsule, a pill, a reward, a spray, an ampule, a chewing gum, and a chew toy.

12 . A gummi food comprising the composition of claim 1 .

13 . A chewing gum comprising the composition of claim 1 .

14 . The composition of claim 1 present in a format selected from the group consisting of: a liquid for spritzing into an oral or nasal opening, a liquid for misting, a lozenge, a buccal strip, and a suppository.

15 . The composition of claim 14 present in a device comprising a mask or a tube that can deliver said liquid for misting into a nasal passage.

16 . The composition of claim 1 further comprising at least one vitamin selected from the group consisting of: vitamin A carotenoids, B1 thiamin, B2 riboflavin, B3 niacin, B5 panthenic acid, B6, pyridoxal, B7 biotin, B9 folic acid/folate, B12 cobalamin, C ascorbate/ascorbic acid, D2 ergocalciferol, D3 cholcalciferol, K1 phylloquinone, K2 menaquinone, retinol, and retinyl ester.

17 . The composition of claim 1 further comprising at least one mineral selected from the group consisting of: selenium, lithium, potassium, iron, phosphorus, zinc, manganese, and magnesium.

18 . The composition of claim 16 further comprising at least one mineral selected from the group consisting of: selenium, lithium, potassium, iron, phosphorus, zinc, manganese, and magnesium.

Assignees

• Postrel Richard

Inventors

• Postrel Richard

Classifications

• A23K20/137

  containing two hetero atoms, of which at least one is nitrogen · CPC title

• A23K20/158

  Fatty acids; Fats; Products containing oils or fats · CPC title

• A23K20/111 Primary

  Aromatic compounds · CPC title

• A61K9/16

  Agglomerates; Granulates; Microbeadlets {; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction (A61K9/20 takes precedence if the final form is a tablet; microspheres with drug-free outer coating, microcapsules A61K9/50; mixture of different granules, microcapsules, (coated) microparticles A61K9/5084; nanoparticles A61K9/51)} · CPC title

• A61K36/185

  Magnoliopsida (dicotyledons) · CPC title